Genetic Testing Company 23andMe Going Public At $3.5 Billion Valuation, Focus On More Therapeutics https://t.co/VU1h5dhoT3

— Christie Law Office (@ChristieLawOfc) February 10, 2021

Genetic Testing Company 23andMe Going Public At $3.5 Billion Valuation, Focus On More Therapeutics https://t.co/VU1h5dhoT3

via http://twitter.com/ChristieLawOfc/status/1359598388828909568